News

May 4, 2011 -- Two new clinical studies will use the Carillon Mitral Contour System, an investigational device for percutaneous treatment of functional mitral regurgitation (FMR).

Home May 09, 2011
Home
News

May 6, 2011 — In the case of angioplasty and stenting, readmission rates due to procedural complications are less than 1 percent, according to a study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.

Home May 06, 2011
Home
News

May 6, 2011 – Rhythmia Medical Inc. and Endosense have engaged in a joint development project to integrate the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter into Rhythmia’s advanced three-dimensional cardiac mapping, visualization and navigation system.

Home May 06, 2011
Home
News

May 6, 2011 – The U.S. Food and Drug Administration has released its list of pre-market approval (PMA) decisions for new or enhanced medical devices from March 2011.

Home May 06, 2011
Home
News

May 6, 2011 – The report recommends training focused on three levels of competency based on the individual interventional cardiologist's level of experience with simple and complex cases, including patients with challenging anatomy.

Home May 06, 2011
Home
Feature | Dave Fornell

In a move that will likely have a significant impact how many patients are treated for carotid artery disease, the U.S. Food and Drug Administration (FDA) has cleared the use of a stent to treat standard-risk surgical patients. Prior to the approval, carotid stenting was only indicated for used in high-risk surgical patients who were often denied the standard-of-care of carotid endarterectomy surgery.

Home May 06, 2011
Home
News

May 6, 2011 – New data presented at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators (ICDs) to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting. Preliminary results from the ST-DETECT Trial using high-fidelity intracardiac electrogram (EGM) signals in ICDs show a low spontaneous coronary event rate (such as heart attack) among these patients.

Home May 06, 2011
Home
News

May 6, 2011 – A substance secreted by the heart that is associated with congestive heart failure and renal failure is not predictive of reduction in systolic blood pressure in patients treated with renal artery stenting, according to results from the HERCULES trial. Data was presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions in Baltimore.

Home May 06, 2011
Home
News

May 6, 2011 – African American patients who undergo angioplasty and stenting fare worse over the long run than patients of other races, regardless of socioeconomic status. In fact, the risk of dying within about three years is more than twice as high among African Americans, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.

Home May 06, 2011
Home
News

May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to defibrillator shock. Instead, the authors found that increased mortality risk associated with these shocks is not attributed to the defibrillator shock itself, but rather to the underlying medical condition leading to atrial and ventricular arrhythmias.

Home May 06, 2011
Home
News

May 6, 2011 – Functionality in the echo ultrasound market drives satisfaction as providers push the bounds of what the technology can do to treat an increasing number of patients at risk for cardiovascular disease. Vendors have responded to these demands with new systems and new technology over the last couple of years.

Home May 06, 2011
Home
Technology

May 5, 2011 – Volcano Corp. announced a supply agreement with ev3, a Covidien company, under which Volcano will supply its intravascular ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated in Volcano's EagleEye catheter product line, this new product will be capable of running on Volcano's global installed base of 5,000 systems.

Home May 05, 2011
Home
Technology

May 5, 2011 – A new warranty program is available in the United States that covers Boston Scientific’s cardiac resynchronization defibrillator (CRT-D) devices and leads in the event of chronic phrenic nerve stimulation (PNS).

Home May 05, 2011
Home
News

May 5, 2011 – GE Healthcare is showing a complete portfolio of integrated electrophysiology (EP) products featuring electrical signals recording and anatomical imaging at the lowest dose, 3-D rotational angiography capabilities, and components integration.

Home May 05, 2011
Home
News

May 5, 2011 – GE scientists are already studying additive manufacturing techniques to reduce labor and costs on ultrasound devices. Here, the key aspect is the transducer, which is expensive to produce using current manufacturing techniques.

Home May 05, 2011
Home
Subscribe Now